Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia. - Wikidata - awgldk - TriplyDB

Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia.

Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia.

http://www.wikidata.org/entity/Q44557805

about

Hematopoietic stem cell transplantation for people with sickle cell disease Hematopoietic stem cell transplantation for people with ß-thalassaemia major Hematopoietic stem cell transplantation for people with sickle cell disease Stem cell transplantation for people with ß thalassaemia major Hematopoietic stem cell transplantation for people with ß-thalassaemia major Hematopoietic stem cell transplantation for children with sickle cell disease Indications and Results of HLA-Identical Sibling Hematopoietic Cell Transplantation for Sickle Cell Disease Hematopoietic stem cell transplantation in sickle cell disease: patient selection and special considerations Alternative donor transplant of benign primary hematologic disorders Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia Umbilical cord blood: an evolving stem cell source for sickle cell disease transplants Primer on tumor immunology and cancer immunotherapy Update of hematopoietic cell transplantation for sickle cell disease Minor antigens on transfused RBCs crossprime CD8 T cells but do not induce full effector function Adult stem cells and their trans-differentiation potential--perspectives and therapeutic applications Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin.Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel.Advancement of pediatric blood and marrow transplantation research in North America: priorities of the Pediatric Blood and Marrow Transplant Consortium.Acute chest syndrome: sickle cell disease.Hematopoietic stem cell transplantation for people with ß-thalassaemia major.Hematopoietic stem cell transplantation for patients with sickle cell disease: progress and future directions.Modeling promising nonmyeloablative conditioning regimens in nonhuman primates.Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases.Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial.Allogeneic hematopoietic stem cell transplantation for sickle cell disease: the time is now.Sensitization to minor antigens is a significant barrier in bone marrow transplantation and is prevented by CD154:CD40 blockade.New insights into haematopoietic stem cell transplantation for patients with haemoglobinopathies.Sickle cell disease: old discoveries, new concepts, and future promise.Hematopoietic stem cell function in a murine model of sickle cell disease Correction of murine hemoglobinopathies by prenatal tolerance induction and postnatal nonmyeloablative allogeneic BM transplants.Hematopoietic Stem Cell Transplantation in Adult Sickle Cell Disease: Problems and Solutions.Umbilical cord blood transplantation for children with thalassemia and sickle cell disease.Hematopoietic transplantation for bone marrow failure syndromes and thalassemia.The hope and the reality of reduced intensity transplants in children with malignant diseases.Reduced-intensity allogeneic hematopoietic stem cell transplantation for acute leukemias: 'what is the best recipe?'.Fludarabine-based nonmyeloablative stem cell transplantation for sickle cell disease with and without renal failure: clinical outcome and pharmacokinetics Immune parameter analysis of children with sickle cell disease on hydroxycarbamide or chronic transfusion therapy Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype.HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease.Molecular therapies in beta-thalassaemia.

P2860

Q24185759-BD478DC0-00D4-439B-8F86-F29F898D1311 Q24193101-F4B9638C-97ED-4AAA-BCF6-00702BE2048B Q24202852-59CCBF81-8B54-488B-BA82-957066674883 Q24235816-126485D6-16FF-49BF-A544-273C2FAA39EE Q24236027-6534E773-B48A-4ADF-B787-460D2C16EF9B Q24240994-A1092917-DEA9-4109-A538-C3AE1EBFC616 Q26779359-2EDBE615-12E6-4343-997F-D0BA28C29F9C Q26800236-FABA3ABB-7345-430B-AE6F-CCD0143540D7 Q26823398-2D2E642F-CA7E-4EDB-87DD-C7791FA50082 Q26824116-FB74A602-C848-4195-A8CA-75B0BD7818F5 Q26853559-55D82C1B-6FC4-42C6-8608-2CE053D0665A Q27001126-0585A37E-C0B2-4A9F-928D-36B6F9626C97 Q28083007-A66AFF70-D901-46D9-92FE-9429416DC207 Q28652702-DFCAE12E-ED15-4F51-AC85-C61CE7F0D704 Q30479159-8A8B5835-5629-48F9-8FDD-A61B2D817F74 Q33363625-27F51BC2-C015-4977-A18C-54D450951209 Q33558770-E421B32C-7374-4854-9928-F96024C49087 Q33937843-089F33A1-490E-4A11-8CF2-B905719AEA91 Q34187526-1A5CD340-6BCA-40A7-94BE-8C1714773D47 Q34546216-9D3D4FFE-EEEB-4A99-8455-12D8AE5D53DC Q34625467-692C4E9E-2E2D-4AB0-8067-16EBE2D24052 Q34729799-B0D6FB12-18F5-4EF8-9B87-27F956620F0B Q34907163-B52AA79D-945B-4A04-9BAD-072217F91A25 Q35073850-E42285B3-C169-434E-B7ED-9028112F5B81 Q35153756-F6F12178-4F68-4952-8315-E33729017A3F Q35372567-81D9B763-F00E-4ED4-8262-C37A54657630 Q35688840-67CA0E98-9BD1-4C11-9502-EB4125163B1A Q35723452-073C79A6-A43B-48EE-9AE1-B97647EB1988 Q36023349-625DFAFF-B510-48C8-8D09-5F6BB4F00473 Q36027459-850E625A-B957-4862-A090-2D2D424BC22E Q36038875-993929EA-FE8C-4A1C-A04A-1A2FB413AEB2 Q36090062-5D497922-A577-4536-8528-87DA99A35C8A Q36090202-D62CCD16-1030-47DC-98F5-1DCA768EE664 Q36090213-EC691C58-1FA3-4970-BE5C-83AF0C8DAF00 Q36182976-D10245AD-AC58-4F3F-98AC-B3969799840C Q36298161-8195C0B5-A6BA-4876-A55F-3E3F14881C7B Q36343931-FB14AB2D-368F-4EF9-8388-E571B711E57B Q36423553-CC697E25-62C3-4FAC-8D54-BD1517207EF7 Q36425417-4C74E1B1-4A64-41DB-8BE8-65998D2AE1B9 Q36665342-9C319A6F-BF8B-4095-98A1-CA5D085D6977

P2860

Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia.

http://www.wikidata.org/entity/Q44557805

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Results of minimally toxic non ...... l anemia and beta-thalassemia.

@en

Results of minimally toxic non ...... l anemia and beta-thalassemia.

@nl

type

label

Results of minimally toxic non ...... l anemia and beta-thalassemia.

@en

Results of minimally toxic non ...... l anemia and beta-thalassemia.

@nl

prefLabel

Results of minimally toxic non ...... l anemia and beta-thalassemia.

@en

Results of minimally toxic non ...... l anemia and beta-thalassemia.

@nl

P1433

Q44557805-3B9D2FC9-DD25-4622-93BF-281AF4B00870

P1476

Q44557805-1EF302D9-9E37-470B-8CCD-5EE90279281B

P2093

Q44557805-1C569068-458D-47D2-97EB-4E87CF7C7E07

Q44557805-4C89B7A7-6502-47D0-A9A5-5C300549274C

Q44557805-5223433D-4AC7-49CB-9791-34196BECF0E5

Q44557805-63DE8589-FA73-4FBA-9DE8-EFFE58803016

Q44557805-984072AC-09B4-4529-BE7F-92FCB9FC18E4

Q44557805-9A7D0444-D93A-4E05-A550-0A69E75DBA53

Q44557805-A71FAE94-25E4-4E97-8D7C-66DF93B31DA9

Q44557805-EC78FB39-57F0-4BE5-A594-F7756672E5AC

P304

Q44557805-B08D142A-C84B-4E1C-B5A1-AB42C47263EE

P31

Q44557805-0DC74BA0-56C7-4D49-BC4B-5895F8C25A8D

P356

Q44557805-5FBFB6F5-7340-457D-9445-1EA01E509CFD

P433

Q44557805-700CBE33-195E-45A0-96BB-630353DEB3B2

P478

Q44557805-5BBC0B68-FB64-4A54-847E-583BFE178C7D

P50

Q44557805-573A74D6-3513-4FFD-B2E2-385545260354

Q44557805-B206D882-3395-479A-A1DC-6D62179E5E52

P577

Q44557805-87AE5540-F043-40D2-B112-5C4BA949F958

P698

Q44557805-B1075934-7CBB-4EC3-B979-78D8E5502C5C

P921

Q44557805-9041E5FB-A458-4866-9B59-7105CB12A76B

P356

S1083-8791(03)00192-7

P1433

Biology of Blood and Marrow Transplantation

P1476

Results of minimally toxic non ...... l anemia and beta-thalassemia.

@en

P2093

Allen R Chen

http://www.w3.org/2001/XMLSchema#string

Ann Woolfrey

http://www.w3.org/2001/XMLSchema#string

Ephraim J Fuchs

http://www.w3.org/2001/XMLSchema#string

James F Casella

http://www.w3.org/2001/XMLSchema#string

Mark C Walters

http://www.w3.org/2001/XMLSchema#string

Michael Amylon

http://www.w3.org/2001/XMLSchema#string

Richard J Jones

http://www.w3.org/2001/XMLSchema#string

Robert Iannone

http://www.w3.org/2001/XMLSchema#string

P304

519-528

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S1083-8791(03)00192-7

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Rainer F. Storb

Keith M. Sullivan

P577

2003-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12931121

http://www.w3.org/2001/XMLSchema#string

P921